2021-01-03,b'$CPRX major stock movement -2.34 % change recently https://t.co/KT0faIAR6D'
2021-01-03,b'$LUVU to divulge ongoing merger talks happening now in New York\nhttps://t.co/fK8PPZ6hwp\n$PMT $JRJR $EPAZ $LGCY $CPRX $EQGP $EPZM $EPGL $EPAY $EPAM $EOMN $EOD $ENZC $ENZ'
2021-01-02,b'$CPRX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/kQfhDQrfRr #CatalystPharmaceuticals #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/UCm7ayr2nH'
2021-01-02,b'$CPRX Valuation is starting to make more sense now $3.01. \n https://t.co/cjDg2jzMhO'
2021-01-02,"b""RT @kylewdennis: Another Video Watch List for next week's action! Click here to watch it for FREE: ----&gt; https://t.co/TtOEgR4x5P \n\nStocks m\xe2\x80\xa6"""
2021-01-02,"b'RT @kylewdennis: Market choppy today but a lot of biotechs were super strong! Booked about $8,200+ in profits. What a day! $AMRN $ADAP $ACH\xe2\x80\xa6'"
2021-01-02,b'$CPRX substantial price changes on this stock -2.34 % https://t.co/KT0faIAR6D'
2021-01-01,b'$CPRX  Lets see $$3.67 \xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd https://t.co/cjDg2jzMhO'
2020-12-31,"b'Added more $CPRX to the portfolio\nStock Portfolio (% weight):\n$INVA - 38%\n$ENST - 22%\n$EA - 16%\n$VNDA - 6%\n$CPRX - 6%\n$MED - 5%\n$IMKTA - 5%\n$BIIB - 2%\n$MTEX &lt; 1%\n\nAs of 5/15/20 when I started this strategy, my stock portfolio is up 65% vs 32% $SPY'"
2020-12-31,b'$CPRX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators: https://t.co/ob5JlQNZn7 #CatalystPharmaceuticals #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/tzJAuL8gz9'
2020-12-31,b'RT @Guy_LeBlanc: $LXXGF was recently added to @Stocktwits !!!  Another great application to follow intelligent investors and gather valuabl\xe2\x80\xa6'
2020-12-31,b'Closed $CPRX'
2020-12-31,b'RT @SeekingAlpha: $CPRX - Catalyst Pharmaceuticals: Attractive Valuation Has Priced In Risks. https://t.co/e24kAiTXF2 #investing #finance #\xe2\x80\xa6'
2020-12-31,b'Accumulating more $CPRX today. Will update portfolio on market close along with summary for 2020 and top picks for 2021.'
2020-12-31,b'RT @Guy_LeBlanc: $LXXGF was recently added to @Stocktwits !!!  Another great application to follow intelligent investors and gather valuabl\xe2\x80\xa6'
2020-12-31,b'$LXXGF was recently added to @Stocktwits !!!  Another great application to follow intelligent investors and gather valuable information!\n\n$TTOO $TRIL $IDXX $CRSP $NVAX $CPRX $INVA $BDSI $BMRN $VRTX  $VYGR $TMO $MIR $SONA'
2020-12-30,b'RT @ThebullMike: $CPRX Delay in data release is worrysome. Data were due this quarter. With only half day of trading left before a long wee\xe2\x80\xa6'
2020-12-30,b'$CPRX Delay in data release is worrysome. Data were due this quarter. With only half day of trading left before a long weekend my hope of getting good results are fading away. If they release bad data tomorrow the market will have time to digest it in the long weekend'
2020-12-30,"b'Added more $MTEX to the portfolio\nStock Portfolio (% weight):\n$INVA - 39%\n$ENST - 22%\n$EA - 16%\n$VNDA - 6%\n$MED - 5%\n$IMKTA - 5%\n$CPRX - 4%\n$BIIB - 2%\n$MTEX &lt; 1%\n\nAs of 5/15/20 when I started this strategy, my stock portfolio is up 64% vs 32% $SPY'"
2020-12-30,"b'Long $SFT, $OSS\nClose $ACRT, $CPRX\n\nUpdated Portfolio\n\n $NVAX $NTDOY $ORMP $FRHC  $TSNP $GTHX $KL $SFT $OSS'"
2020-12-30,b'Rose Above 50 DMA today: $TFFP $CPRX ... https://t.co/qwiJH6vr1O'
2020-12-30,b'$CPRX - Catalyst Pharmaceuticals: Attractive Valuation Has Priced In Risks. https://t.co/6vBm2cGhnK  https://t.co/qDKUMPldw3'
2020-12-30,b'RT @SeekingAlpha: $CPRX - Catalyst Pharmaceuticals: Attractive Valuation Has Priced In Risks. https://t.co/e24kAiTXF2 #investing #finance #\xe2\x80\xa6'
2020-12-30,b'$CPRX - Catalyst Pharmaceuticals: Attractive Valuation Has Priced In Risks. https://t.co/e24kAiTXF2 #investing #finance #stocks'
2020-12-30,b'$CPRX was analyzed by 5 analysts. The buy consensus is at 100%. So analysts seem to be very confident about $CPRX. https://t.co/U3Czd55kBW https://t.co/mtFstRth8S'
2020-12-30,b'A Magic Formula For A New Year $FF $MED $MSB $TPL $VHC $FIZZ $PETS $CPRX $HEAR $CODX https://t.co/Nf1QFUAnVR'
2020-12-29,b'2020-12-28 Short sale volume (not short interest) for $CPRX is 55%. https://t.co/98fO0eTJ77 $SRPT 44% $PFE 32% $XLV 74%'
2020-12-29,"b'Initiating $CPRX and $MTEX to portfolio\nStock Portfolio (% weight):\n$INVA - 39%\n$ENST - 22%\n$EA - 16%\n$VNDA - 6%\n$MED - 5%\n$IMKTA - 5%\n$CPRX - 4%\n$BIIB - 2%\n$MTEX &lt; 1%\n\nAs of 5/15/20 when I started this strategy, my stock portfolio is up 63% vs 32% $SPY'"
2020-12-29,b'(4/4) $CPRX is a biotech generating cash every quarter on top of $117MM in the bank and no debt. Patent protects cash flows. Closure of doctors offices and competitive alternatives are a threat. Meantime they can work on acquiring or developing next big thing.'
2020-12-29,b'(3/4) FUD case for $CPRX:\n\n\xf0\x9f\x92\xa3Tiny stock market cap $350MM\n\n\xf0\x9f\x92\xa3Significant volatility\n\n\xf0\x9f\x92\xa3Limited market for patients with LEMS\n\n\xf0\x9f\x92\xa3Small pipeline for new drug development\n\nFinal conclusion: \xf0\x9f\x91\x87\xf0\x9f\x91\x87\xf0\x9f\x91\x87'
2020-12-29,b'(2/4) FOMO case for $CPRX:\n\n\xf0\x9f\x9a\x80FY20 sales tracking 15% higher vs FY19\n\n\xf0\x9f\x9a\x8086% gross margins!\n\n\xf0\x9f\x9a\x80Awarded patent through 2034\n\n\xf0\x9f\x9a\x80Applying for Japan entry\n\n\xf0\x9f\x9a\x80$117MM of cash for acquisitions/buybacks/dividend\n\n\xf0\x9f\x9a\x80Recent pullback due to COVID - patients not able to see doctors\n\n\xf0\x9f\x91\x87\xf0\x9f\x91\x87'
2020-12-29,"b'@TheDustyBC $CPRX great stock play , just grabbed 2k shares myself ... don\xe2\x80\x99t see too many buys out there other than that at the moment'"
2020-12-29,b'I am going to start accumulating $CPRX starting today. I will update my portfolio after the market closes.'
2020-12-29,"b""$CPRX:\n\nNew Insider Filing on CATALYST PHARMACEUTICALS, INC.'s\n\nDirector\n\nRICHARD J DALY:\n\nhttps://t.co/dxuuyfjN93"""
2020-12-29,"b""$CPRX:\n\nNew Insider Filing on CATALYST PHARMACEUTICALS, INC.'s\n\nChief Medical Officer\n\nGARY INGENITO:\n\nhttps://t.co/FJHTeTzIdn"""
2020-12-29,b'2020-12-28 Short sale volume (not short interest) for $XLP is 62%. https://t.co/WSr4v43Ttf $RMTI 57% $PTON 48% $FXI 54% $CPRX 55%'
2020-12-29,"b""$CPRX:\n\nNew Insider Filing on CATALYST PHARMACEUTICALS, INC.'s\n\nChief Operating Officer\n\nSTEVE MILLER:\n\nhttps://t.co/yvEVWYDkno"""
2020-12-29,"b""$CPRX:\n\nNew Insider Filing on CATALYST PHARMACEUTICALS, INC.'s\n\nPresident and CEO\n\nPATRICK J MCENANY:\n\nhttps://t.co/WP5yuoCZkj"""
2020-12-28,b'@KROptions Some calls I\xe2\x80\x99m watching\n\n$LXRX\n$CERC\n$CPRX\n$SGMO\n$EIGR\n$ATNM'
2020-12-28,b'$CPRX showing signs of bounce off of 50DMA (3.39) support. Looking for return to 200DMA (3.80+).'
2020-12-28,b'$CPRX New Form 4 for Catalyst Pharmaceuticals\nFrom our Stock News Alerts App'
2020-12-28,b'@PJ_Matlock @Pharmdca $DVAX &amp; $CPRX are also doing the same thing and look pretty good'
2020-12-28,"b""Rose Above Previous Day's High today: $CRAI $EPAY $EVV $FLV $UMAY $QADA $FMAO $PFIS $AMTB $CPRX $BSRR $ATLO $CNBKA $AMNB $SMMF $FNLC $RBB $TZOO $BBIG $GOAC ... https://t.co/TBYRpvrFqi"""
2020-12-28,"b'@ToPdAd_InCrypto $CPRX- I\xe2\x80\x99m at ~10% loss, tired of avg it down .. once I\xe2\x80\x99m even I\xe2\x80\x99m out .. can\xe2\x80\x99t wait'"
2020-12-28,b'Take a look at this Watchlist: \n$CPRX $LEDS $STAF\n\n #scnDollHiVol   \n\nDateTime: 2020-12-28 12:44 ET'
2020-12-28,b'@ibracadabra_S $CPRX looking good H4-D1 looks like a move is coming'
2020-12-27,b'$CPRX https://t.co/iEhtzcZt1A'
2020-12-27,b'RT @ThebullMike: Positions open: \n$AUPH run-up to PDUFA \n$CPRX 5C JAN21 waiting for Phase III results from the SMA Type 3 proof of concept\xe2\x80\xa6'
2020-12-27,b'Positions open: \n$AUPH run-up to PDUFA \n$CPRX 5C JAN21 waiting for Phase III results from the SMA Type 3 proof of concept trial before the end of 2020'
2021-01-07,b'My entry wasn\xe2\x80\x99t that great but I\xe2\x80\x99m glad to finally see some upward movement $CPRX'
2021-01-07,"b'@umarashraf28 I\xe2\x80\x99d suggest putting some gains in $CPRX looks like it\xe2\x80\x99s getting ready to run , $INO strong consolidation at these levels as well ...'"
2021-01-07,b'$CPRX\n\nA ONE AND ONLY \n\npatented drug pharma company going for a song\n\nhttps://t.co/54Se65Nww0'
2021-01-07,"b""Piper says Catalyst's Firdapse commercial business performing as expected\n$CPRX"""
2021-01-07,b'Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporat.. $CPRX https://t.co/IwVW1F7Svf'
2021-01-07,b'@umarashraf28 Interested to see how you feel about $CPRX $INO'
2021-01-07,"b'Catalyst Pharma sees FY20 revenue as high as $118M, provides update on product expansion $CPRX https://t.co/9lyyMTHDhR'"
2021-01-07,b'@Stocktwits $CPRX $INO $GNUS $CGC LONGS \xf0\x9f\xa6\xbe'
2021-01-06,b'$CPRX New Form 8-K for Catalyst Pharmaceuticals\nFrom our Stock News Alerts App'
2021-01-06,"b'A Form 8-K [Press/News Current Report] filing has been made with the SEC:  $CPRX #CatalystPharmaceuticals, Inc  https://t.co/yc2cCCXymI'"
2021-01-06,"b'Catalyst Firdapse commercial business performing as expected, says Piper Sandler $CPRX https://t.co/gBRZxB4zkT'"
2021-01-06,"b""Also, if you are new to $CPRX here's a background article on Finpedia for you https://t.co/Dc5MFjlUWb"""
2021-01-06,"b'$CPRX / Catalyst Pharmaceuticals files form 8-K - Financial Statements and Exhibits, Other Events -  FORM 8-K https://t.co/PP8lDoSETu'"
2021-01-06,"b'Catalyst Firdapse commercial business performing as expected, says Piper Sandler\n$CPRX'"
2021-01-06,"b""$CPRX's price moved above its 50-day Moving Average on January 4, 2021. View odds for this and other indicators: https://t.co/LJ6nc5ceIi #CatalystPharmaceuticals #stockmarket #stock #technicalanalysis #money #trading #investing #daytrading #news #today https://t.co/0akubfzDMm"""
2021-01-06,b'$CPRX I\xe2\x80\x99ll probably buy on the dip. Still need to do more research.  -4.11 % https://t.co/KT0faIAR6D'
2021-01-06,b'$CPRX $NRG $TSN NEW ARTICLE : 3 Non-Cyclical Stocks to Consider https://t.co/N4exA3hBxF Get all the latest $CPRX related news here : https://t.co/AVWv7LKC6J'
2021-01-06,b'$CPRX $NRG $TSN - 3 Non-Cyclical Stocks to Consider https://t.co/l4F4esie8R https://t.co/LTNJdsijvE'
2021-01-06,b'$CPRX: Catalyst Pharma announces strategic plan for product portfolio expansion and provides corporate update https://t.co/obcIVf0KHB'
2021-01-06,b'$CPRX Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update https://t.co/aiCNwGvazt'
2021-01-06,b'Catalyst Pharmaceuticals awaiting schedule or decision in FDA suit\n$CPRX'
2021-01-06,"b""Catalyst Pharmaceuticals decides not to pursue Kennedy's disease indication\n$CPRX"""
2021-01-06,b'Catalyst Pharmaceuticals decides not to pursue SMA Type 3 indication\n$CPRX'
2021-01-06,"b""$CPRX:\n\nNew Insider Filing on CATALYST PHARMACEUTICALS, INC.'s\n\nDirector\n\nDONALD A DENKHAUS:\n\nhttps://t.co/2NX13SO5YY"""
2021-01-06,b'Catalyst plans to present hypotheses on MuSK-MG Phase 3 trial to FDA in 1H21\n$CPRX'
2021-01-06,b'Catalyst Pharmaceuticals expects additional PK work on Firdapse LA in 2021\n$CPRX'
2021-01-06,b'Catalyst Pharmaceuticals sees 2020 Firdapse revenues approx. $118M \n$CPRX'
2021-01-06,"b'Catalyst expands focus to earlier stage programs, validated tech platforms\n$CPRX'"
2021-01-06,b'$CPRX - Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update https://t.co/o9aGowlZD5 https://t.co/Js3NZihLR8'
2021-01-06,b'$CPRX Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success\nFrom our Stock News Alerts App'
2021-01-06,"b'$CPRX [15s. delayed]: Issued Press Release on January 06, 08:07:00: Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update https://t.co/P3pjWLcSUR'"
2021-01-06,b'$CPRX Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update'
2021-01-06,b'$CPRX: Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update'
2021-01-06,b'$CPRX Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update\nhttps://t.co/G25fT54RSA'
2021-01-06,b'RT @mediasentiment: $CPRX  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 128'
2021-01-06,b'$CPRX  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 128'
